XML 35 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
Nature of Business and Accounting Policies (Details) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
M
product
Dec. 31, 2011
Dec. 31, 2010
Product revenues allowances and reserve categories                      
Advertising Expenses                 $ 58,600,000 $ 30,800,000 $ 0
Number of products                 2    
Net income (loss) attributable to Vertex (76,148,000) (57,543,000) (64,931,000) 91,590,000 158,629,000 221,110,000 (174,069,000) (176,096,000) (107,032,000) 29,574,000 (754,626,000)
Basic EPS $ 0.35 $ 0.27 $ 0.31 $ (0.44) $ (0.76) $ (1.06) $ 0.85 $ 0.87 $ 0.50 $ (0.14) $ 3.77
Cash, cash equivalents and marketable securities 1,300,000,000               1,300,000,000    
Product revenues, net                      
Discount rate for payments made within 30 days (percent)                 2.00%    
Period prior to the labeled expiration date in which distributors have right to return unopened, unprescribed INCIVEK (teleprevir) (in months)                 6    
Period after the labeled expiration date in which distributors have right to return unopened, unprescribed INCIVEK (teleprevir) (in months)                 12    
Activity related to product revenues allowances and reserve categories                      
Balance, Beginning of Period       69,363,000       0 69,363,000 0  
Provision related to current period sales                 (294,025,000) (123,618,000)  
Adjustments related to prior period sales                 5,482,000    
Credits/payments made                 (293,477,000) (54,255,000)  
Balance, End of Period 75,393,000       69,363,000       75,393,000 69,363,000 0
Trade allowances
                     
Activity related to product revenues allowances and reserve categories                      
Balance, Beginning of Period       11,162,000       0 11,162,000 0  
Provision related to current period sales                 (55,913,000) (38,228,000)  
Adjustments related to prior period sales                 29,000    
Credits/payments made                 (61,688,000) (27,066,000)  
Balance, End of Period 5,416,000       11,162,000       5,416,000 11,162,000  
Rebates, Chargebacks and Discounts
                     
Activity related to product revenues allowances and reserve categories                      
Balance, Beginning of Period       52,659,000       0 52,659,000 0  
Provision related to current period sales                 (216,942,000) (75,145,000)  
Adjustments related to prior period sales                 3,883,000    
Credits/payments made                 (209,924,000) (22,486,000)  
Balance, End of Period 63,560,000       52,659,000       63,560,000 52,659,000  
Product Returns
                     
Activity related to product revenues allowances and reserve categories                      
Balance, Beginning of Period       340,000       0 340,000 0  
Provision related to current period sales                 (2,067,000) (553,000)  
Adjustments related to prior period sales                 1,498,000    
Credits/payments made                 (1,053,000) (213,000)  
Balance, End of Period 2,852,000       340,000       2,852,000 340,000  
Other Incentives
                     
Activity related to product revenues allowances and reserve categories                      
Balance, Beginning of Period       5,202,000       0 5,202,000 0  
Provision related to current period sales                 (19,103,000) (9,692,000)  
Adjustments related to prior period sales                 72,000    
Credits/payments made                 (20,812,000) (4,490,000)  
Balance, End of Period $ 3,565,000       $ 5,202,000       $ 3,565,000 $ 5,202,000